Article Details
Retrieved on: 2021-06-25 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As it approaches the end of a distinguished run, AstraZeneca's type 2 diabetes franchise is showing its age. Sales are in decline for Byetta and ...
Article found on: www.fiercepharma.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here